TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol, Drug: Remifentanil | Arm Label: Bispectral Index Monitor; Type: EXPERIMENTAL; Interventions: Drug: Propofol, Drug: Remifentanil, Device: Bispectral Index Monitor | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): Bispectral Index Monitor, Control | Intervention Type: DRUG; Name: Remifentanil; Assigned to Arm(s): Bispectral Index Monitor, Control | Intervention Type: DEVICE; Name: Bispectral Index Monitor; Assigned to Arm(s): Bispectral Index Monitor
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
D: Arm Label: BIS group; Type: EXPERIMENTAL; Interventions: Device: Bispectral Index Monitor | Arm Label: MAC Alert; Type: ACTIVE_COMPARATOR; Interventions: Device: Electronic MAC alert | Intervention Type: DEVICE; Name: Bispectral Index Monitor; Assigned to Arm(s): BIS group | Intervention Type: DEVICE; Name: Electronic MAC alert; Assigned to Arm(s): MAC Alert

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: Arm Label: EEG guided protocol; Type: EXPERIMENTAL; Interventions: Device: a pragmatic EEG-guided anesthetic protocol | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: a pragmatic EEG-guided anesthetic protocol; Assigned to Arm(s): EEG guided protocol
B: N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2
D: Arm Label: desflurane and sevoflurane; Type: N/A; Interventions: Other: The intervention will be Mini-Mental Status Examination (MMSE) | Intervention Type: OTHER; Name: The intervention will be Mini-Mental Status Examination (MMSE); Assigned to Arm(s): desflurane and sevoflurane

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: N/A
B: Arm Label: anesthesia monitoring; Type: EXPERIMENTAL; Interventions: Device: bispectral index monitoring | Arm Label: no bispectral index monitoring; Type: EXPERIMENTAL; Interventions: Device: bispectral index monitoring | Intervention Type: DEVICE; Name: bispectral index monitoring; Assigned to Arm(s): anesthesia monitoring, no bispectral index monitoring
C: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall
Brief Summary: The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.


Options:
A: Arm Label: 70% Nitrous Oxide; Type: OTHER; Interventions: Other: Nitrous Oxide | Arm Label: No Nitrous Oxide; Type: OTHER; Interventions: Other: No Nitrous Oxide | Intervention Type: OTHER; Name: Nitrous Oxide; Assigned to Arm(s): 70% Nitrous Oxide | Intervention Type: OTHER; Name: No Nitrous Oxide; Assigned to Arm(s): No Nitrous Oxide
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: air | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Nitrous oxide | Intervention Type: DRUG; Name: air; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Nitrous oxide; Assigned to Arm(s): 2
C: Arm Label: BIS Monitor guided algorithm; Type: EXPERIMENTAL; Interventions: Device: BIS Monitor guided algorithm | Arm Label: Volatile anesthetic guided algorithm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volatile anesthetic guided algorithm | Intervention Type: DEVICE; Name: BIS Monitor guided algorithm; Assigned to Arm(s): BIS Monitor guided algorithm | Intervention Type: BEHAVIORAL; Name: Volatile anesthetic guided algorithm; Assigned to Arm(s): Volatile anesthetic guided algorithm
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Bispectral index protocol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: End tidal anesthetic gas-guided | Intervention Type: BEHAVIORAL; Name: Bispectral index protocol; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: End tidal anesthetic gas-guided; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)
Brief Summary: The purpose of this research study is to determine if adding Metformin, a drug that reduces insulin resistance, to birth control pills will reduce the risk of developing type 2 diabetes, high blood pressure. high lipid levels and heart disease in women with PCOS


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): 2
B: Arm Label: Metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Behavioral: Lifestyle Intervention | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Lifestyle Intervention | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Metformin, Placebo
C: Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral metformin | Arm Label: Oral contraceptive; Type: ACTIVE_COMPARATOR; Interventions: Drug: oral contraceptive | Intervention Type: DRUG; Name: oral metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: oral contraceptive; Assigned to Arm(s): Oral contraceptive
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Desorelle | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin, Drug: Desorelle | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Desorelle; Assigned to Arm(s): 2, 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan
Brief Summary: To measure the effects of a Medical health plan-directed automated telephone self-management support system (ATSM) on patient outcomes among ethnically diverse health plan enrollees with diabetes.


Options:
A: Arm Label: UC; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TM; Type: EXPERIMENTAL; Interventions: Other: Telemonitoring | Intervention Type: OTHER; Name: Telemonitoring; Assigned to Arm(s): TM
B: Arm Label: Breastfeeding promotion intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Breastfeeding promotion intervention | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding promotion intervention; Assigned to Arm(s): Breastfeeding promotion intervention
C: Arm Label: 1 concurrent smoking cessation; Type: EXPERIMENTAL; Interventions: Behavioral: behavioral counseling plus contingency management | Arm Label: 2 deferred smoking cessation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: behavioral counseling plus contingency management | Intervention Type: BEHAVIORAL; Name: behavioral counseling plus contingency management; Assigned to Arm(s): 1 concurrent smoking cessation, 2 deferred smoking cessation
D: Arm Label: ATSM Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ATSM Intervention | Arm Label: WAIT LIST Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ATSM Intervention; Assigned to Arm(s): ATSM Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Famotidine Compared With Esomeprazole in the Prevention of Ulcer Complications in Patients With Acute Coronary Syndrome or Myocardial Infarction
Brief Summary: Aspirin and clopidogrel +/- heparin or thrombolytic co-therapy is well established and effective treatment for unstable cardiac patients. However, the major complication was gastrointestinal bleeding (GIB) due to peptic ulcer. In the prevention of GIB, anti-ulcer drug either H2-receptor antagonist (H2RA) and proton pump inhibitor (PPI) were commonly prescribed. There has been no prospective controlled study to compare the efficacy of these two classes of anti-ulcer drugs.


Options:
A: Arm Label: Proton pump inhibitor (PPI); Type: EXPERIMENTAL; Interventions: Drug: Pantoprazole | Arm Label: Normal saline; Type: PLACEBO_COMPARATOR; Interventions: Other: Saline (0.9%) | Intervention Type: DRUG; Name: Pantoprazole; Assigned to Arm(s): Proton pump inhibitor (PPI) | Intervention Type: OTHER; Name: Saline (0.9%); Assigned to Arm(s): Normal saline
B: Intervention Type: DRUG; Name: Esomeprazole Sodium; Assigned to Arm(s): N/A
C: Intervention Type: OTHER; Name: Biventricular pacing post cardiac surgery; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: esomeprazole 20 mg daily | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: famotidine 40 mg daily | Intervention Type: DRUG; Name: esomeprazole 20 mg daily; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: famotidine 40 mg daily; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Significance of Low-Dose Aspirin on Ovarian Responsiveness, Uterine Hemodynamics and Pregnancy Outcome in in Vitro Fertilization and in Intracytoplasmic Sperm Injection: A Randomized, Placebo-Controlled Double-Blind Study
Brief Summary: In this study we hypothesized that low-dose aspirin therapy (100 mg daily) improves ovarian responsiveness, uterine haemodynamics and clinical pregnancy rates in unselected subjects undergoing IVF/ICSI when the treatment is started concomitantly with controlled ovarian hyperstimulation.


Options:
A: Arm Label: Routine low-dose aspirin; Type: EXPERIMENTAL; Interventions: Drug: Low dose aspirin | Arm Label: No aspirin; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Test-indicated low-dose aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose aspirin | Intervention Type: DRUG; Name: Low dose aspirin; Assigned to Arm(s): Routine low-dose aspirin, Test-indicated low-dose aspirin
B: Arm Label: aspirin; Type: EXPERIMENTAL; Interventions: Drug: Aspirin | Arm Label: blank; Type: OTHER; Interventions: Other: Blank | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): aspirin | Intervention Type: OTHER; Name: Blank; Assigned to Arm(s): blank
C: Arm Label: Aspirin group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Aspirin group
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acetylsalicylic acid | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Acetylsalicylic acid; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Laparoscopic Hysterectomy: a Clinical Randomized Trial Comparing Conventional and Robot-assisted(Da Vinci®)Techniques
Brief Summary: The aim of this study is to compare conventional with robot-assisted (Da Vinci®) laparoscopic hysterectomy regarding operating time peri-operative outcome and costs.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Laparoscopic Hysterectomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot-assisted (Da Vinci®) laparoscopic hysterectomy | Intervention Type: PROCEDURE; Name: Conventional Laparoscopic Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Robot-assisted (Da Vinci®) laparoscopic hysterectomy; Assigned to Arm(s): 2
B: Arm Label: Robot-assisted; Type: EXPERIMENTAL; Interventions: Procedure: Hysterectomy | Arm Label: Laparoscopic Hysterectomy; Type: EXPERIMENTAL; Interventions: Procedure: Hysterectomy | Intervention Type: PROCEDURE; Name: Hysterectomy; Assigned to Arm(s): Laparoscopic Hysterectomy, Robot-assisted
C: Arm Label: single-port LAVH; Type: EXPERIMENTAL; Interventions: Procedure: single-port LAVH | Intervention Type: PROCEDURE; Name: single-port LAVH; Assigned to Arm(s): single-port LAVH
D: Arm Label: Robot assisted laparoscopic hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot assisted laparoscopic hysterectomy | Arm Label: Abdominal hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Abdominal hysterectomy; Assigned to Arm(s): Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Robot assisted laparoscopic hysterectomy; Assigned to Arm(s): Robot assisted laparoscopic hysterectomy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Laparoscopic Hysterectomy: a Clinical Randomized Trial Comparing Conventional and Robot-assisted(Da Vinci®)Techniques
Brief Summary: The aim of this study is to compare conventional with robot-assisted (Da Vinci®) laparoscopic hysterectomy regarding operating time peri-operative outcome and costs.


Options:
A: Arm Label: Robot assisted laparoscopic hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot assisted laparoscopic hysterectomy | Arm Label: Abdominal hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Abdominal hysterectomy; Assigned to Arm(s): Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Robot assisted laparoscopic hysterectomy; Assigned to Arm(s): Robot assisted laparoscopic hysterectomy
B: Arm Label: Laparoscopic Radical Hysterectomy; Type: EXPERIMENTAL; Interventions: Procedure: Laparoscopic Radical Hysterectomy + pelvic lymphadenectomy | Arm Label: Abdominal radical hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal radical hysterectomy | Intervention Type: PROCEDURE; Name: Laparoscopic Radical Hysterectomy + pelvic lymphadenectomy; Assigned to Arm(s): Laparoscopic Radical Hysterectomy | Intervention Type: PROCEDURE; Name: Abdominal radical hysterectomy; Assigned to Arm(s): Abdominal radical hysterectomy
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Laparoscopic Hysterectomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot-assisted (Da Vinci®) laparoscopic hysterectomy | Intervention Type: PROCEDURE; Name: Conventional Laparoscopic Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Robot-assisted (Da Vinci®) laparoscopic hysterectomy; Assigned to Arm(s): 2
D: Arm Label: Transperitoneal; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transperitoneal laparoscopic aortic lymphadenectomy | Arm Label: Extraperitoneal; Type: EXPERIMENTAL; Interventions: Procedure: Extraperitoneal laparoscopic aortic lymphadenectomy | Intervention Type: PROCEDURE; Name: Transperitoneal laparoscopic aortic lymphadenectomy; Assigned to Arm(s): Transperitoneal | Intervention Type: PROCEDURE; Name: Extraperitoneal laparoscopic aortic lymphadenectomy; Assigned to Arm(s): Extraperitoneal

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Laparoscopic Hysterectomy: a Clinical Randomized Trial Comparing Conventional and Robot-assisted(Da Vinci®)Techniques
Brief Summary: The aim of this study is to compare conventional with robot-assisted (Da Vinci®) laparoscopic hysterectomy regarding operating time peri-operative outcome and costs.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Total Abdominal Radical Hysterectomy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Total Laparoscopic or Robotic Radical Hysterectomy | Intervention Type: PROCEDURE; Name: Total Abdominal Radical Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Total Laparoscopic or Robotic Radical Hysterectomy; Assigned to Arm(s): 2
B: Arm Label: Robotic Surgery; Type: EXPERIMENTAL; Interventions: Procedure: Robotic surgery | Arm Label: Laparoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic Surgery | Intervention Type: PROCEDURE; Name: Robotic surgery; Assigned to Arm(s): Robotic Surgery | Intervention Type: PROCEDURE; Name: Laparoscopic Surgery; Assigned to Arm(s): Laparoscopy
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Laparoscopic Hysterectomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot-assisted (Da Vinci®) laparoscopic hysterectomy | Intervention Type: PROCEDURE; Name: Conventional Laparoscopic Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Robot-assisted (Da Vinci®) laparoscopic hysterectomy; Assigned to Arm(s): 2
D: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: robotic laparoscopic sacrocolpopexy | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic Sacral Colpopexy | Intervention Type: PROCEDURE; Name: robotic laparoscopic sacrocolpopexy; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Laparoscopic Sacral Colpopexy; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tobacco Cessation Via Public Health Dental Clinics (PHD2)
Brief Summary: The study will examine the effectiveness of public health dental practitioners using a brief office based intervention designed to help patients quit smoking or smokeless tobacco use, as compared to usual care.


Options:
A: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
B: Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Brief tobacco counseling | Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief tobacco counseling; Assigned to Arm(s): 2
C: Arm Label: Varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline Tartarate | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: Varenicline Tartarate; Assigned to Arm(s): varenicline

Answer: B